Optimizing NIH 2025

Working Group Members

Keith R. Yamamoto, PhD (Chair) Special Advisor to the Chancellor, Science Policy and Strategy; Vice Chancellor for Research, Emeritus; Professor of Cellular and Molecular Pharmacology, Emeritus; University of California San Francisco; National Academy of Sciences; National Academy of Medicine Sue Biggins, PhD Director and Professor, Basic Sciences Division; Fred Hutchinson Cancer Center; Affiliate Professor; University of Washington; Investigator, Howard Hughes Medical Institute; National Academy of Sciences Daniel Colón-Ramos, PhD McConnell Duberg Professor of Neuroscience & Cell Biology; Director of the Center for Neurodevelopment and Plasticity, Wu Tsai Institute; Yale University School of Medicine; Founder Ciencia Puerto Rico; National Academy of Medicine Carol Greider, PhD Distinguished Professor of Molecular, Cell, and Developmental Biology; University of California, Santa Cruz; National Academy of Sciences; National Academy of Medicine; Nobel Laureate, Physiology or Medicine, 2009 India Hook-Barnard, PhD Executive Director, Engineering Biology Research Consortium Jo Handelsman, PhD Howard Hughes Medical Institute Professor; Director, Wisconsin Institute for Discovery; Vilas Research Professor; University of Wisconsin– Madison; National Academy of Sciences H. Robert Horvitz, PhD David H. Koch Professor of Biology; Massachusetts Institute for Technology (MIT); Howard Hughes Medical Institute; National Academy of Sciences; National Academy of Medicine; Nobel Laureate, Physiology or Medicine 2002 Judith Kimble, PhD Howard Hughes Medical Institute Investigator Emerita; Emeritus Professor, Henry Vilas Professor, Vannevar Bush Professor of Biochemistry; University of Wisconsin–Madison; National Academy of Sciences Richard M. Myers, PhD Chief Scientific Officer and M. A. Loya Chair in Genomics HudsonAlpha Institute for Biotechnology

Jodi Nunnari, PhD Director of the Bay Area Institute, Altos Labs, Inc.; Distinguished Professor Emerita, Department of Molecular and Cellular Biology, University of California, Davis; European Molecular Biology Organization; American Academy of Arts and Sciences; National Academy of Sciences Bodo Stern, PhD Chief of Strategic Initiatives, Howard Hughes Medical Institute Shirley Tilghman, PhD President and Professor Emerita of Molecular Biology and Public Affairs, Princeton University; National Academy of Sciences; National Academy of Medicine Harold Varmus, MD Lewis Thomas University Professor of Medicine, Weill Cornell Medicine; Former Director of the NIH; Former Director of the National Cancer Institute; National Academy of Sciences; National Academy of Medicine; National Medal of Science; Nobel Laureate, Physiology or Medicine 1989 Mary Woolley, MA President, Research!America; National Academy of Medicine Elias Zerhouni, MD Emeritus Professor Johns Hopkins University, former President, Global R&D, Sanofi; Former Director of the NIH; National Academy of Engineering; National Academy of Medicine

©2025 The authors thank Cathleen Shaw at the HudsonAlpha Institute for Biotechnology for her design and production of the online and printed report. Online report: https://online.flippingbook.com/ view/492769090/ Staff Ann Reid Senior Advisor, Optimizing NIH Lynn Marquis Executive Director, Coalition for the Life Sciences

Made with FlippingBook - Online magazine maker